Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Miguel Fontecha Barriuso"'
Autor:
Juan Guerrero-Mauvecin, Miguel Fontecha-Barriuso, Ana M. López-Diaz, Alberto Ortiz, Ana B. Sanz
Publikováno v:
Nefrología (English Edition), Vol 44, Iss 1, Pp 10-22 (2024)
Receptor interacting protein kinase 3 (RIPK3) is an intracellular kinase at the crossroads of cell death and inflammation. RIPK3 contains a RIP homotypic interaction motif (RHIM) domain which allows interactions with other RHIM-containing proteins an
Externí odkaz:
https://doaj.org/article/6e1a3a5d469f4402aaef8b624d0d898e
Autor:
Diego Martin-Sanchez, Miguel Fontecha-Barriuso, Julio M. Martinez-Moreno, Adrian M. Ramos, Maria D. Sanchez-Niño, Melania Guerrero-Hue, Juan A. Moreno, Alberto Ortiz, Ana B. Sanz
Publikováno v:
Nefrología, Vol 40, Iss 4, Pp 384-394 (2020)
Cell death is a finely regulated process occurring through different pathways. Regulated cell death, either through apoptosis or regulated necrosis offers the possibility of therapeutic intervention. Necroptosis and ferroptosis are among the best stu
Externí odkaz:
https://doaj.org/article/5bb81152fa554ddf9ffb6ac19468d001
Autor:
Miguel Fontecha-Barriuso, Ana M. Lopez-Diaz, Juan Guerrero-Mauvecin, Veronica Miguel, Adrian M. Ramos, Maria D. Sanchez-Niño, Marta Ruiz-Ortega, Alberto Ortiz, Ana B. Sanz
Publikováno v:
Antioxidants, Vol 11, Iss 7, p 1356 (2022)
Acute kidney injury (AKI) and chronic kidney disease (CKD) are interconnected conditions, and CKD is projected to become the fifth leading global cause of death by 2040. New therapeutic approaches are needed. Mitochondrial dysfunction and oxidative s
Externí odkaz:
https://doaj.org/article/60e7643fb6e7493a9010674fb8817e79
Autor:
Miguel Fontecha-Barriuso, Diego Martín-Sanchez, Julio M. Martinez-Moreno, Daniela Cardenas-Villacres, Susana Carrasco, Maria D. Sanchez-Niño, Marta Ruiz-Ortega, Alberto Ortiz, Ana B. Sanz
Publikováno v:
Redox Biology, Vol 32, Iss , Pp - (2020)
Omeprazole, a proton pump inhibitor used to treat peptic ulcer and gastroesophageal reflux disease, has been associated to chronic kidney disease and acute interstitial nephritis. However, whether omeprazole is toxic to renal cells is unknown. Omepra
Externí odkaz:
https://doaj.org/article/e594dab90e2845f7b432784f16cd8f38
Autor:
Julio M. Martinez-Moreno, Miguel Fontecha-Barriuso, Diego Martín-Sánchez, Maria D. Sánchez-Niño, Marta Ruiz-Ortega, Ana B. Sanz, Alberto Ortiz
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Acute kidney injury (AKI) and chronic kidney disease (CKD) are the most severe consequences of kidney injury. They are interconnected syndromes as CKD predisposes to AKI and AKI may accelerate CKD progression. Despite their growing impact on the glob
Externí odkaz:
https://doaj.org/article/7cdf0a00dd884b3d9d0b461fa66de742
Autor:
Diego Martin-Sanchez, Jonay Poveda, Miguel Fontecha-Barriuso, Olga Ruiz-Andres, María Dolores Sanchez-Niño, Marta Ruiz-Ortega, Alberto Ortiz, Ana Belén Sanz
Publikováno v:
Nefrología (English Edition), Vol 38, Iss 2, Pp 125-135 (2018)
The term acute tubular necrosis was thought to represent a misnomer derived from morphological studies of human necropsies and necrosis was thought to represent an unregulated passive form of cell death which was not amenable to therapeutic manipulat
Externí odkaz:
https://doaj.org/article/d23522a5f1614d12bf1ce50581165b5f
Autor:
Juan Guerrero-Mauvecin, Miguel Fontecha-Barriuso, Ana M. López-Diaz, Alberto Ortiz, Ana B. Sanz
Publikováno v:
Nefrología (English Edition).
Autor:
Ramio Cabello, Miguel Fontecha-Barriuso, Diego Martin-Sanchez, Ana M. Lopez-Diaz, Susana Carrasco, Ignacio Mahillo, Carmen Gonzalez-Enguita, Maria D. Sanchez-Niño, Alberto Ortiz, Ana B. Sanz
Publikováno v:
Biomedicines, Vol 9, Iss 2, p 217 (2021)
Background: Despite the term acute kidney injury (AKI), clinical biomarkers for AKI reflect function rather than injury and independent markers of injury are needed. Tubular cell death, including necroptotic cell death, is a key feature of AKI. Cyclo
Externí odkaz:
https://doaj.org/article/b1dfe7a9cfa547de8a8f549562cb248c
Autor:
Diego Martin-Sanchez, Juan Guerrero-Mauvecin, Miguel Fontecha-Barriuso, Nerea Mendez-Barbero, Maria Laura Saiz, Ana M. Lopez-Diaz, Maria D. Sanchez-Niño, Susana Carrasco, Pablo Cannata-Ortiz, Marta Ruiz-Ortega, Alberto Ortiz, Ana B. Sanz
Publikováno v:
J Am Soc Nephrol
BACKGROUND: Receptor-interacting protein kinase 3 (RIPK3), a component of necroptosis pathways, may have an independent role in inflammation. It has been unclear which RIPK3-expressing cells are responsible for the anti-inflammatory effect of overall
Autor:
Miguel Fontecha-Barriuso, Diego Martin-Sanchez, Julio Manuel Martinez-Moreno, Maria Monsalve, Adrian Mario Ramos, Maria Dolores Sanchez-Niño, Marta Ruiz-Ortega, Alberto Ortiz, Ana Belen Sanz
Publikováno v:
Biomolecules, Vol 10, Iss 2, p 347 (2020)
Chronic kidney disease (CKD) is one of the fastest growing causes of death worldwide, emphasizing the need to develop novel therapeutic approaches. CKD predisposes to acute kidney injury (AKI) and AKI favors CKD progression. Mitochondrial derangement
Externí odkaz:
https://doaj.org/article/fccae0862cd145579820a1a17b62ac68